Literature DB >> 2548419

Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines.

S R Bolin1, J F Ridpath.   

Abstract

Serum was obtained at weekly intervals after vaccination of 6 healthy calves with either of 2 commercially available monovalent modified-live bovine viral diarrhea (BVD) virus vaccines. Detectable neutralizing antibodies to each of 10 cytopathic and 10 noncytopathic isolates of BVD virus were produced by 1 or more of the calves by 14 days after vaccination, but no calf produced detectable neutralizing antibodies to all 20 BVD viruses. At that time, precipitating antibodies against viral-induced polypeptides of approximately 115,000; 80,000; 56,000; 48,000; 39,000; and 25,000 daltons were detected in sera from some calves. Also at that time, specificity of the antibodies for polypeptides of certain viruses was detected. At 21 days after vaccination, each calf produced neutralizing antibodies to all 20 BVD viruses. At that time, precipitating antibodies to each of the aforementioned viral induced polypeptides were detected in serum from each calf. Precipitating antibodies to viral induced polypeptides of 61,000 and 37,000 daltons were detected in samples of sera obtained from some calves at 42 days after vaccination.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548419

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Evaluation of the serum virome in calves persistently infected with Pestivirus A, presenting or not presenting mucosal disease.

Authors:  Matheus N Weber; Samuel P Cibulski; Simone Silveira; Franciele M Siqueira; Ana Cristina S Mósena; Mariana S da Silva; Juliana C Olegário; Ana Paula M Varela; Thaís F Teixeira; Matheus V Bianchi; David Driemeier; Saulo P Pavarini; Fabiana Q Mayer; Paulo M Roehe; Cláudio W Canal
Journal:  Virus Genes       Date:  2018-09-14       Impact factor: 2.332

2.  Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay.

Authors:  R W Fulton; J T Saliki; L J Burge; J M d'Offay; S R Bolin; R K Maes; J C Baker; M L Frey
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.

Authors:  Lingshu Wang; J Oriol Sunyer; Leonard J Bello
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Simple Indirect Enzyme-Linked Immunosorbent Assay to Detect Antibodies Against Bovine Viral Diarrhea Virus, Based on Prokaryotically Expressed Recombinant MBP-NS3 Protein.

Authors:  Pezhman Mahmoodi; Masoud Reza Seyfi Abad Shapouri; Masoud Ghorbanpour; Mohammad Rahim Haji Hajikolaei; Mohsen Lotfi; Mahdi Pourmahdi Boroujeni; Maryam Daghari
Journal:  Jundishapur J Microbiol       Date:  2015-01-14       Impact factor: 0.747

5.  Production of monoclonal antibody against recombinant NS3 protein of bovine viral diarrhea virus (NADL strain).

Authors:  Masood Reza Seyfi Abad Shapouri; Maryam Ekhtelat; Masood Ghorbanpoor Najaf Abadi; Mohsen Lotfi; Mohamad Rashno
Journal:  Vet Res Forum       Date:  2016-09-15       Impact factor: 1.054

Review 6.  Molecular biology of bovine viral diarrhea virus and its interactions with the host.

Authors:  R O Donis
Journal:  Vet Clin North Am Food Anim Pract       Date:  1995-11       Impact factor: 3.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.